Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$465,478,121
-$62,526,182 QoQ
Shares Held
506,081
+3.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $2,972,093,575 across 11 Drug Manufacturers - General names. LLY ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,409,868 | $1,077,948,133 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
506,081 | $465,478,121 | |
| 3 | ABBV |
AbbVie Inc.
|
2,065,016 | $449,120,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,517,435 | $302,822,256 | |
| 5 | AZN |
Astrazeneca PLC
|
1,444,637 | $284,911,309 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,017,219 | $141,769,812 | |
| 7 | PFE |
Pfizer Inc
|
3,274,513 | $91,948,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,465,433 | $88,878,511 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $465,478,121 | 506,081 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $528,004,303 | 491,313 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $199,370,374 | 261,298 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $174,515,719 | 223,873 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $208,487,764 | 252,434 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $211,899,332 | 274,481 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $238,232,809 | 268,904 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $252,737,732 | 279,151 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $219,189,452 | 281,749 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $171,964,897 | 295,006 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $182,473,266 | 339,719 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $151,796,632 | 323,674 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $92,782,811 | 270,173 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $97,779,520 | 267,274 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $83,717,901 | 258,908 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $79,121,846 | 244,030 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $50,423,456 | 176,078 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $56,391,694 | 204,155 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $55,799,499 | 241,504 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $60,828,997 | 265,027 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $54,199,097 | 290,114 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $47,526,265 | 281,487 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $39,891,241 | 269,499 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $39,737,142 | 242,034 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||